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Purpose: To evaluate the effects of iodine contrast agent on diffusion signal intensity 
and apparent diffusion coefficient (ADC) in diffusion-weighted imaging (DWI) studies 
in MRI examination just after computed tomography (CT) contrast imaging. 
 
Methods: On a 1.5 T MRI scanner, ADC was calculated from the signal intensity of 
DWI (b = 0 and 1000) using phantoms filled with contrast agent (0, 4.5, 6.0, 9.0, 30, 
and 60 mg I/mL). We evaluated the signal intensities of DWI and ADC in 10 patients (3 
women, 7 men, 35–68 years old) examined by MRI study less than 40 minutes after 
injection of 100 mL of iopamidol (300 mg I/mL) for CT study. 
 
Results: The DWI signal increased until a CT value of 190 HU, but showed no changes 
above this value. The ADC decreased with increases in CT value. Less than 40 minutes 
after injection of iopamidol (300 mg I/mL) for CT scan, the signal intensity of DWI was 
significantly increased and ADC was significantly decreased.  
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Conclusion: It is necessary to recognise the rate of decrease of ADC, because it is 
dependent on the density of iodine contrast agents. 
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1. Introduction 
  Various examination modalities are often used in the same patient for diagnosis, and 
both computed tomography (CT) and magnetic resonance imaging (MRI) examinations 
may be performed consecutively on the same day. 
Several studies have indicated that contrast agents used for CT and MRI may adversely 
influence the results of the other imaging modality (1–6). In these reports, it was 
suggested that iodinated contrast agents shorten T1 and T2 on MRI examination, and 
cause high signal intensity on T1-weighted imaging and low signal intensity on 
T2-weighted imaging (1–2). 
 Body diffusion-weighted imaging (DWI) is often performed in MRI examination to 
detect malignant tumours and allow discrimination between benign and malignant 
masses. Detection of a malignant tumour is based on the increase in signal intensity on 
DWI, and discrimination between benign and malignant tumours is based on the 
apparent diffusion coefficient (ADC). However, several factors may alter the ADC 
(7–11). Iodinated contrast agents are predicted to affect the ADC due to their high 
viscosity and large molecular size.  
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  In this study, a phantom experiment was performed to evaluate the changes in 
diffusion signal intensity and ADC by iodinated contrast agents in MRI-DWI study 
performed just after CT contrast imaging. 
 
2. Materials and methods 
  Institutional review board approval was obtained for the study design and review of 
patient records and images. First, the distribution of contrast agent used in CT 
examination to the internal organs was examined. The average CT values of brain 
meningiomas of 20 patients (19 women, 1 man, 48–87 years old) and the kidney cortex 
of 20 patients (7 women, 13 men, 35–57 years old) 2 minutes after injection of 
iopamidol (300 mg I/mL) with a viscosity of 4.5 mPa·s at 37°C (12–15), and the 
bladders of 12 patients (8 women, 4 men, 32–67 years old) 15 minutes after injection of 
iopamidol (300 mg I/mL) were measured by setting the regions of interest (ROI). The 
devices used were a Light Speed Pro16 (General Electric Co.) and ProSeed-SA helical 
CT scanner (General Electric Co.). ROIs were set manually by three operators and the 
mean values were used in this study. 
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  The CT values of diluted contrast agent phantoms were also measured. Iopamidol 
(300 mg I/mL) was diluted with physiological saline solution to concentrations of 0, 4.5, 
6.0, 9.0, 30 and 60 mg I/mL and kept in the original bottle to avoid contamination with 
other substances in the phantom. CT images and CT values of the phantoms are shown 
in Figure 1. T1- and T2-relaxation times for the phantoms were calculated. 
T1-relaxation times were measured with change to inversion times of 20–2000 ms with 
the inversion recovery method. T2-relaxation times were measured with change to TE 
27–280 ms/TR = 4000 ms with spin-echo sequence. The device used was a Magnetom 
Symphony 1.5T (Siemens AG). 
  Furthermore, the diluted contrast agent phantoms were subjected to DWI. The 
scanning parameters were TR 4000/TE107 ms/SENSE factor 2 with echo planar 
imaging using an 8-Ch head coil. The ADC was calculated from the signal intensity at b 
= 0 and 1000. 
  In addition, the signal intensities of T1-weighted images (TR 550/TE15 ms), 
T2-weighted images (TR 3000/TE120 ms/ETL11) and DWI (TR 10000/TE ms), were 
measured for 10 patients (3 women, 7 men, 35–68 years old) examined by MRI less 
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than 40 minutes after injection of 100 mL of iopamidol (300 mg I/mL) in the CT study. 
The regions measured were the renal parenchyma and peripheral fat tissue. Three 
operators manually designated a circular region of interest (ROI) and calculated the 
mean signal value. The relative tissue ratio was calculated with each value. 
Relative tissue ratio = Signal value of kidney / Signal value of fat (1) 
The fat signal of the circumference was used for normalising kidney signal intensity 
because the MRI signal changed depending on the signal gain. 
Furthermore, the ADC was calculated from the signal intensity at b = 0 and 1000. The 
Wilcoxon signed-rank test was used for statistical comparisons of all data. 
 
3. Results 
  The average CT values and standard deviation of the brain meningiomas and kidney 
cortex 2 minutes after injection and of the bladder 15 minutes after injection in 20 
patients are shown in Table 1. CT values ranged from 180 to 200 HU. The calculated T1 
and T2 values of the iodine phantom are shown in Figure 2. 
The T2 value decreased with increasing CT value of solutions, but there were no 
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marked changes in T1 value. 
  DWI results of the phantoms are shown in Figure 3 and an ADC mapping image is 
shown in Figure 4. In addition, the signal intensities of DWI and ADC of phantoms are 
shown in Figures 5 and 6, respectively. The DWI signal values increased until a CT 
value of 190 HU, but there were no further changes above this value. The ADC 
decreased with increases in CT value. 
  The relative tissue ratios calculated for the kidney cortex and fat tissue on MRI less 
than 40 minutes after injection of iopamidol (300 mg I/mL) on CT scans are shown in 
Figure 7. After administration of the iodine contrast agent, the signal intensity on T2WI 
was slightly decreased, but the difference was not significant. No significant differences 
were seen on T1WI. On DWI, the signal intensity was significantly increased after 
administration of iodine contrast agent. As shown in Figure 8, the ADC of the kidney 
cortex showed a significant decrease after injection of iodine contrast agent. 
 
4. Discussion 
 With the recent development of parallel MRI, DWI has often been used in clinical 
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medicine to both search for tumours and for discrimination diagnosis. In addition, CT 
and MRI examinations are often performed consecutively on the same day. After CT 
contrast imaging, diffusion of water molecules may be restricted by the iodinated 
contrast agents with large molecular size and high viscosity (16) even when diluted. 
Thus, the signal intensity of DWI and the ADC are predicted to be influenced by the 
iodinated contrast agents. Therefore, we performed a phantom experiment to evaluate 
the changes in diffusion signal intensity and ADC in MRI-DWI study performed just 
after CT contrast imaging. 
  When MRI examination is performed after CT examination, it usually takes over 40 
minutes after iodine contrast agent administration due to preparations required for MRI 
and transfer of the patient. Over this period, the iodine is thought to remain in the brain, 
the renal parenchyma and bladder. The CT values were less than 180 HU except in the 
bladder after 40 minutes because the CT values after 5 minutes were 180–200 HU. 
  There have been some previous reports regarding the influence of T1WI and T2WI in 
MRI after injection of iodine (1–2); we performed similar experiments and came to 
similar conclusions. The T2 value decreased with increasing concentration of iodine; 
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however, if the CT value was less than 200 HU, there was little difference and this 
represented no obstacle to diagnosis (See Figures 1 and 2). However, the signal intensity 
of DWI may be increased with even small CT values (Figure 5). We feel that the signal 
intensity of DWI in increasing with concentration of iodine reaches a plateau due to 
conflict between the increase in signal by diminished ADC and decrease in signal by 
diminished T2-value. However, the diffusion signal increases at lower concentrations of 
iodine because the ratio of signal decrease caused by T2 shortening is small. 
  This was confirmed with clinical images. The signal intensities of DWI in the renal 
parenchyma with and without administration of iodine 40 minutes previously are shown 
in Figure 7. The signal intensity increased significantly after administration of the 
iodine contrast agent. However, this may not pose a problem for diagnosis because these 
masses showed uniform increases in contrast intensity. However, these changes should 
be recognised. DWI is often used in clinical medicine to both search for tumours and for 
diagnosis. In particular, small differences in ADC are often used to distinguish between 
benign and malignant tumour (17–25). 
  As shown in Figure 8, the ADC of the renal parenchyma was significantly decreased 
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after administration of iodine contrast agent. Therefore, it is necessary to pay sufficient 
attention to avoid making a false diagnosis in discrimination of tumours based on ADC, 
because the ADC decreases with increasing CT value, as shown in Figures 6 and 8.  
 Clinical images are shown in Figure 9 and 10. Figure 9 shows the ADC map of DWI 
only on MRI examination without administration of iodine, while Figure 10 shows an 
image taken 6 months later in the same patient. This image shows the ADC map of MRI 
examination 30 minutes after administration of contrast agent on CT examination. 
In Figure 10, it can be seen that the ADC of the liver and kidney had decreased. 
 
5. Conclusions 
In case of DWI just after injection of iodine contrast agent for CT examination, the 
DWI signal increased slightly and the ADC decreased under the influence of iodine. The 
effects of iodine on diffusion-weighted MRI were evaluated, when MRI study was 
performed immediately after administration of iodine contrast agent for CT examination. 
The signal intensity of DWI showed a slight increase, while ADC decreased due to the 
iodine contrast agent. 
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  It is necessary to recognise the rate of decrease of ADC, because it is dependent on 
the density of iodine contrast agents used. 
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Figure legends 
Fig. 1 CT images and CT values of the diluted iodine contrast phantom. The contrast 
phantom was diluted with physiological saline solution to a concentration of 0, 4.5, 6.0, 
9.0, 30 or 60 mg I/mL. 
Fig. 2 The calculated T1 and T2 values of the iodine phantom. With increases in CT 
value of solutions, the T2 value decreased but the T1 value did not change markedly. 
Fig. 3 DWI (TR 4000/TE107 ms/SENSE factor 2 with EPI) of diluted iodine contrast 
phantom. 
Fig. 4 ADC mapping image (calculated from signal intensity at b = 0 and 1000) of 
diluted iodine contrast phantom. 
Fig. 5 Signal intensity of DWI of diluted iodine contrast phantom. The signal intensity 
of DWI increased until a CT value of 190 HU, but there were no further changes at 
higher values. 
Fig. 6 Signal intensity of ADC of diluted iodine contrast phantom. The ADC decreased 
with increases in CT value. 
Fig. 7 Relative tissue ratio calculated for the kidney cortex and fat tissue on MRI less 
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than 40 minutes after injection of iopamidol (300 mg I/mL) for CT scan. After iodine 
contrast agent administration, the signal intensity of T2WI was decreased slightly, while 
that of DWI showed a significant increase. 
Fig. 8 ADC of the kidney cortex after injection of iodine contrast agent. The ADC was 
significantly decreased after iodine contrast agent injection. 
Fig. 9 ADC map of DWI only on MRI examination without administration of iodine. 
Fig.10 An image after 6 months in the same patient as shown in Figure 9. This image 
shows the ADC map of MRI examination 30 minutes after administration of contrast 
agent on CT examination. The ADC of liver and kidney had decreased. 
Table 1 Average CT values and standard deviation of brain meningiomas and kidney 
cortex and of the bladder 2 and 15 minutes after injection of contrast agent, respectively, 













meningioma after injected two minutes 204.2 15.2
kidney cortex after injected two minutes 182.3 4.11
bladder after injected 15 minutes 488.2 25.3
Table 1
